Recent studies confirmed that tumor cell-derived IL-1β increases the survival rate of EB virus-induced nasopharyngeal carcinoma via recruiting concentrated granulocytes (Chen et al. 2012). The gene discussed is IL1B; the disease is nasopharyngeal carcinoma.